DELISA: Sensitive nonisotopic assay for GAD65 autoantibodies, a key risk-assessment marker for insulin-dependent diabetes mellitus

Clinical Chemistry

Volumn 42, Issue 2, 1996, Pages 263-269

  Mehta, Harshvardhan B ^a   Vold, Barbara S ^a   Minkin, Svetlana ^a   Ullman, Edwin F ^a  

^a Behring Diagnostics Inc   (United States)

Author keywords

Autoimmune disease; ELISA; Immunoassay; Serology

Indexed keywords

AUTOANTIBODY; DEXTRAN; GLUTAMATE DECARBOXYLASE; PROTEIN A;

ARTICLE; AUTOIMMUNITY; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SEROLOGY;

AUTOANTIBODIES; BACTERIAL PROTEINS; BIOTIN; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTAMATE DECARBOXYLASE; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREPTAVIDIN;

EID: 0030050339     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.2.263     Document Type: Article

References (30)

1. LaPorte RE, Cruickshank KJ. Incidence and risk factors for insulin dependent diabetes. In: National Diabetes Data Group. Diabetes in America: diabetes data compiled 1984. NIH Publ. No. 1985-1468. Bethesda, MD: Department of Health and Human Services, 1985:III-1-12.
2. Castano L, Eisenbarth GS. Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 1990;8: 647-79.
3. Atkinson M, Maclaren N. The pathogenesis of insulin dependent diabetes mellitus. N Engl J Med 1994;331:1428-36.
4. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92:301-3.
5. Diabetes. 1993 vital statistics. Alexandria, VA: American Diabetes Association, 1993:25-36.
6. Stephanson J, Fuller JH. Microvascular and acute complications of IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994;37:278-85.
7. Boitard C. The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects. Diabetologia 1992;35: 1101-12.
8. Reddy S, Bibby NJ, Elliot RB. Ontogeny of islet cell autoantibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse. Diabetologia 1988;31:322-8.
9. Bingley PJ, Christie MR, Bonifacio E, Bonafanti R, Shattock M, Fonte M, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994;43:1304-10.
10. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95:1505-11.
11. Riley WJ, Winter WE, Maclaren NK. Identification of insulin dependent diabetes mellitus before the onset of clinical symptoms. J Pediatr 1988;112:314-6.
12. Bonifacio E, Bingley PJ, Dean BM, Shattock M, Dunger D, Gale EAM, Botazzo GF. Quantification of islet-cell antibodies and prediction of insulin dependent diabetes. Lancet 1990;335:147-9.
13. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS. "Cytoplasmic" islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985;34:617-9.
14. Riley WJ, Maclaren NK, Krischer J, Spiller RP, Silverstein J, Schatz DA, et al. A prospective study of the development of diabetes in relatives of patients with insulin dependent diabetes. N Engl J Med 1990;323:1167-72.
15. Palmer JP. Insulin autoantibodies: their role in the pathogenesis of IDDM. Diabetes Metab Rev 1987;3:1005-15.
16. r autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990;335:1357-60.
17. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin dependent diabetes as GABA synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6.
18. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin dependent diabetes mellitus. J Clin Invest 1992;89:283-92.
19. Blindermann J, Maitre M, Ossola M, Mandel P. Purification and some properties of L-glutamate decarboxylase from human brain. Eur J Biochem 1978;85:143-52.
20. Bu DF, Erlander MG, Hitz BC, Tillakratne NJ, Kaufman DL, Wagener-McPherson CB, et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each coded by a single gene. Proc Natl Acad Sci U S A 1992;89:2115-9.
21. Aanstoot HJ, Sigurdsson E, Jaffe M, Shi Y, Christgau S, Grabbee D, et al. Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 1994;37:917-24.
22. Tuomilehto J, Zimmet P, Mackay I, Keskela P, Vidgren G, Teivanen L, et al. Antibodies to glutamic acid decarboxylase as predictors of insulin dependent diabetes mellitus before clinical onset of disease. Lancet 1994;343:1383-5.
23. Schmidli R, Colman P, Bonifacio E, Botazzo G, Harrison L. High level of concordance between assays for GADAb: the first international GADAb workshop. Diabetes 1994;43:1005-9.
24. Schmidli R, Colman P, Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the second international GADAb workshop. Diabetes 1995; 44:636-40.
25. Moody AJ, Hejnæs KR, Marshall MO, Larsen FS, Boel E, Svendsen I, et al. Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells. Diabetologia 1995;38:14-23.
26. Savage D, Mattson G, Desai S, Nielander G, Morgensen S, Conklin E. Avidin-biotin chemistry: a handbook. Rockford, IL: Pierce Chemical Co., 1992:14-23.
27. Fasman G, ed. Practical handbook of biochemistry and molecular biology. Boca Raton, FL: CRC Press, 1989:305 pp.
28. Bjorck L, Kronvall G. Purification and some properties of streptococcal Protein G. A novel IgG-binding reagent. J Immunol 1984; 133:969-74.
29. Richter W, Endl J, Eiermann TH, Brandt M, Kientsch-Engel R, Thivolet C, et al. Human monoclonal islet cell antibodies from a patient with insulin dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci U S A 1992;89:8467-71.
30. Wasserfall C, Schatz D, Mehta HB, Void B, Krischer J, Atkinson M, Maclaren N. Glutamic acid decarboxylase autoantibodies powerfully predict impending IDD in the general population [Abstract]. Diabetes 1995;44:77A.